Overview
Shanghua Cai practices practicing medicine in Guangzhou, China.
Cai is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Cerebral Hypoxia, and Renal Cell Carcinoma (RCC).
They are actively involved in clinical research, co-authoring 23 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shanghua Cai
Is Shanghua Cai a top-rated expert for Familial Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Shanghua Cai is classified as an Advanced expert for Familial Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shanghua Cai participate in research or clinical trials?
Yes. Shanghua Cai has published 23 articles and abstracts on conditions like Familial Prostate Cancer. You can view a list of Shanghua Cai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Prostate Cancer
- Experienced
- Cerebral HypoxiaCai isExperienced. Learn about Cerebral Hypoxia.
- Prostate CancerCai isExperienced. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)